These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 3791866)
1. Implication of thromboxane in frusemide diuresis in rats. Melki TS; Foegh ML; Ramwell PW Clin Sci (Lond); 1986 Dec; 71(6):647-50. PubMed ID: 3791866 [TBL] [Abstract][Full Text] [Related]
2. [Effects of KW-3635 on the diuretic action of furosemide in rats]. Kawakage M; Ishihara N; Karasawa A; Kase H Nihon Yakurigaku Zasshi; 1993 Jan; 101(1):33-8. PubMed ID: 8444379 [TBL] [Abstract][Full Text] [Related]
3. Thromboxane mediates renal hemodynamic response to infused angiotensin II. Wilcox CS; Welch WJ; Snellen H Kidney Int; 1991 Dec; 40(6):1090-7. PubMed ID: 1837063 [TBL] [Abstract][Full Text] [Related]
4. Renal function in rats with angiotensin II-salt-induced hypertension: effect of thromboxane synthesis inhibition and receptor blockade. Mistry M; Muirhead EE; Yamaguchi Y; Nasjletti A J Hypertens; 1990 Jan; 8(1):75-83. PubMed ID: 2157760 [TBL] [Abstract][Full Text] [Related]
5. Renal effects of the inhibitor of thromboxane A2-synthetase OKY-046. Hatziantoniou C; Papanikolaou N Experientia; 1986 Jun; 42(6):613-5. PubMed ID: 3522267 [TBL] [Abstract][Full Text] [Related]
6. The role of thromboxane A2 (TxA2) in allergic cutaneous reactions and the effect of (E)-3-[p-(1H-imidazol-1-ylmethyl) phenyl]-2-propenoic acid hydrochloride (OKY-046), a TxA2 synthetase inhibitor. Nagai H; Yakuo I; Nakatomi I; Inagaki N; Koda A Prostaglandins Leukot Essent Fatty Acids; 1989 Mar; 35(3):125-30. PubMed ID: 2710796 [TBL] [Abstract][Full Text] [Related]
7. Effect of thromboxane A2 inhibition and antagonism on prostaglandin and leukotriene synthesis in glomerular immune injury. Lianos EA; Bresnahan BA J Lab Clin Med; 1999 Nov; 134(5):478-82. PubMed ID: 10560941 [TBL] [Abstract][Full Text] [Related]
8. Testosterone treatment increases thromboxane function in rat cerebral arteries. Gonzales RJ; Ghaffari AA; Duckles SP; Krause DN Am J Physiol Heart Circ Physiol; 2005 Aug; 289(2):H578-85. PubMed ID: 15764681 [TBL] [Abstract][Full Text] [Related]
10. The role of thromboxane A2 [TxA2] in liver injury in mice. Nagai H; Shimazawa T; Yakuo I; Aoki M; Koda A; Kasahara M Prostaglandins; 1989 Oct; 38(4):439-46. PubMed ID: 2813811 [TBL] [Abstract][Full Text] [Related]
11. Thromboxane A2 and the development of hypertension in spontaneously hypertensive rats. Stier CT; Itskovitz HD Eur J Pharmacol; 1988 Jan; 146(1):129-35. PubMed ID: 3350054 [TBL] [Abstract][Full Text] [Related]
12. Agents combining thromboxane receptor antagonism with thromboxane synthase inhibition: [[[2-(1H-imidazol-1-yl)ethylidene]amino]oxy]alkanoic acids. Cozzi P; Giordani A; Menichincheri M; Pillan A; Pinciroli V; Rossi A; Tonani R; Volpi D; Tamburin M; Ferrario R J Med Chem; 1994 Oct; 37(21):3588-604. PubMed ID: 7932586 [TBL] [Abstract][Full Text] [Related]
13. Intrarenal thromboxane A2 generation reduces the furosemide-induced sodium and water diuresis in cirrhosis with ascites. Pinzani M; Laffi G; Meacci E; La Villa G; Cominelli F; Gentilini P Gastroenterology; 1988 Oct; 95(4):1081-7. PubMed ID: 3165896 [TBL] [Abstract][Full Text] [Related]
14. Antagonism of thromboxane actions in the isolated perfused rat heart. Stahl GL; Darius H; Lefer AM Life Sci; 1986 Jun; 38(22):2037-41. PubMed ID: 2940431 [TBL] [Abstract][Full Text] [Related]
15. Autacoids mediate coronary vasoconstriction induced by nitric oxide synthesis inhibition. Pomposiello S; Yang XP; Liu YH; Surakanti M; Rhaleb NE; Sevilla M; Carretero OA J Cardiovasc Pharmacol; 1997 Nov; 30(5):599-606. PubMed ID: 9388042 [TBL] [Abstract][Full Text] [Related]
17. Role of thromboxane A2 in healing of gastric ulcers in rats. Takahashi S; Shigeta J; Ishikawa M; Kobayashi N; Okabe S Jpn J Pharmacol; 1999 Jan; 79(1):101-7. PubMed ID: 10082323 [TBL] [Abstract][Full Text] [Related]
18. Role of pressor prostanoids in rats with angiotensin II-salt-induced hypertension. Mistry M; Nasjletti A Hypertension; 1988 Jun; 11(6 Pt 2):758-62. PubMed ID: 3164706 [TBL] [Abstract][Full Text] [Related]
19. Reduced myocardial neutrophil accumulation and infarct size following thromboxane synthetase inhibitor or receptor antagonist. Nichols WW; Mehta J; Wargovich TJ; Franzini D; Lawson D Angiology; 1989 Mar; 40(3):209-21. PubMed ID: 2537051 [TBL] [Abstract][Full Text] [Related]
20. Contrasting effect of thromboxane synthase inhibitors and a thromboxane receptor antagonist on the development of angiotensin II-salt-induced hypertension in rats. Mistry M; Nasjletti A J Pharmacol Exp Ther; 1990 Apr; 253(1):90-4. PubMed ID: 2139470 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]